These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17183142)

  • 21. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy.
    Tsougos I; Nilsson P; Theodorou K; Kjellén E; Ewers SB; Jarlman O; Lind BK; Kappas C; Mavroidis P
    Phys Med Biol; 2007 Feb; 52(4):1055-73. PubMed ID: 17264370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal tissue complication probability modelling of tissue fibrosis following breast radiotherapy.
    Alexander MA; Brooks WA; Blake SW
    Phys Med Biol; 2007 Apr; 52(7):1831-43. PubMed ID: 17374914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted radionuclide therapy: theoretical study of the relationship between tumour control probability and tumour radius for a 32P/33P radionuclide cocktail.
    Lechner A; Blaickner M; Gianolini S; Poljanc K; Aiginger H; Georg D
    Phys Med Biol; 2008 Apr; 53(7):1961-74. PubMed ID: 18354241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical validation of the LKB model and parameter sets for predicting radiation-induced pneumonitis from breast cancer radiotherapy.
    Tsougos I; Mavroidis P; Theodorou K; Rajala J; Pitkänen MA; Holli K; Ojala AT; Hyödynmaa S; Järvenpää R; Lind BK; Kappas C
    Phys Med Biol; 2006 Feb; 51(3):L1-9. PubMed ID: 16424572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour control probability (TCP) for non-uniform activity distribution in radionuclide therapy.
    Uusijärvi H; Bernhardt P; Forssell-Aronsson E
    Phys Med Biol; 2008 Aug; 53(16):4369-81. PubMed ID: 18660558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy.
    Her EJ; Reynolds HM; Mears C; Williams S; Moorehouse C; Millar JL; Ebert MA; Haworth A
    Phys Med Biol; 2018 Jun; 63(13):135011. PubMed ID: 29799812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-fire doses from beta-emitting radionuclides in targeted radiotherapy. A theoretical study based on experimentally measured tumor characteristics.
    Enger SA; Hartman T; Carlsson J; Lundqvist H
    Phys Med Biol; 2008 Apr; 53(7):1909-20. PubMed ID: 18364546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation damage, repopulation and cell recovery analysis of in vitro tumour cell megacolony culture data using a non-Poissonian cell repopulation TCP model.
    Stavrev P; Weldon M; Warkentin B; Stavreva N; Fallone BG
    Phys Med Biol; 2005 Jul; 50(13):3053-61. PubMed ID: 15972980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TCP and NTCP: a basic introduction.
    Baumann M; Petersen C
    Rays; 2005; 30(2):99-104. PubMed ID: 16294901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling the effect of spread in radiosensitivity parameters and repopulation rate on the probability of tumour control.
    Stavreva N; Stavrev P; Balabanova A; Nahum A; Ruggieri R; Pressyanov D
    Phys Med; 2019 Jul; 63():79-86. PubMed ID: 31221413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
    Yaromina A; Hölscher T; Eicheler W; Rosner A; Krause M; Hessel F; Petersen C; Thames HD; Baumann M; Zips D
    Radiother Oncol; 2005 Aug; 76(2):206-12. PubMed ID: 16024121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical heterogeneity and tumor control probability.
    Eisbruch A
    Acta Oncol; 2010 Nov; 49(8):1385-7. PubMed ID: 20500028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.
    Søvik A; Malinen E; Bruland ØS; Bentzen SM; Olsen DR
    Phys Med Biol; 2007 Jan; 52(2):499-513. PubMed ID: 17202629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should single or distributed parameters be used to explain the steepness of tumour control probability curves?
    Daşu A; Toma-Daşu I; Fowler JF
    Phys Med Biol; 2003 Feb; 48(3):387-97. PubMed ID: 12608614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimum parameters in a model for tumour control probability including interpatient heterogeneity.
    Webb S
    Phys Med Biol; 1994 Nov; 39(11):1895-914. PubMed ID: 15559999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols.
    Levin-Plotnik D; Hamilton RJ
    Phys Med Biol; 2004 Feb; 49(3):407-24. PubMed ID: 15012010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining the validity of Poissonian models against the birth and death TCP model for various radiotherapy fractionation schemes.
    Horas JA; Olguín OR; Rizzotto MG
    Int J Radiat Biol; 2010 Aug; 86(8):711-7. PubMed ID: 20586544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate cancer.
    Lennernäs B; Albertsson P; Edgren M; Nilsson S
    Oncol Rep; 2007 Nov; 18(5):1299-303. PubMed ID: 17914588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-effect models for risk-relationship to cell survival parameters.
    Daşu A; Toma-Daşu I
    Acta Oncol; 2005; 44(8):829-35. PubMed ID: 16332590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.